In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Indian stock markets experienced sharp losses for the third consecutive session, with Sensex and Nifty falling over 1% each. Escalating Ira...

Experts and health authorities in Russia say the drug shortages are temporary - due to panic- buying and logistical difficulties for suppli...

The Russian invasion has left drugmakers scrambling to find ways for patients enrolled in clinical trials in Ukraine to receive their medic...

Sanctions levied by the US, Britain, Europe and Canada against Russia do not apply to medicine and medical equipment.

Drug maker Wockhardt said on Friday that it partnered with Enso Healthcare, an aggregator for Russian Direct Investment Fund (RDIF) for its...

The Russian government late last year granted Russian drugmaker Pharmasyntez a compulsory licence for one year to manufacture the drug unde...

The Centre has also allowed foreign vaccines included in the emergency use listing maintained by the World Health Organisation to be fast-t...

Avifavir will be delivered to Argentina, Bulgaria, Brazil, Chile, Colombia, Ecuador, El Salvador, Honduras, Kuwait, Panama, Paraguay, Saudi...

The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group produced the first 100,000 courses of the Russ...

Avifavir is Russia’s first COVID-19 drug and has shown high efficacy in treating patients with coronavirus during clinical trials. Avifavir...

Six leading medical centers in Moscow, Smolensk and Nizhny Novgorod are currently participating in clinical trials, including I.M. Sechenov...

A black market has developed in Russia for an antiviral HIV drug explored as a possible treatment for COVID-19, the respiratory disease cau...

The annual growth rate in pharmaceutical exports may almost halve to 7.98% by 2020 from 14.77% CAGR during 2010-2014

Consolidation of pharmacy players in North America has resulted in the presence of leading firms that hold better bargaining power, it adde...

India and Russia are in the process of liberalising registration of new drugs in order to boost bilateral trade in pharmaceutical sector, a...